Peptide Stack
Wolverine stack extended
A four-compound injury-recovery stack combining BPC-157, TB-500, GHK-Cu, and KPV. It is marketed for recovery-focused wellness protocols, but human evidence is limited and the stack is not FDA approved.
Injury HealingTissue RegenerationRecovery Stack
Detail
Overview
A four-compound injury-recovery stack combining BPC-157, TB-500, GHK-Cu, and KPV. It is marketed for recovery-focused wellness protocols, but human evidence is limited and the stack is not FDA approved.
Benefits list
Side effects
Vendor protocol
- Pre-blended 80 mg 5:1:1:1 KLOW-style vial; common daily dose 0.10 mL (~2.67 mg total blend)
Clinical protocol
- No standard clinical protocol; the four-compound stack remains investigational because human data are very limited
- TB-500/thymosin beta-4 is still mainly supported by preclinical and ocular wound-healing research rather than an established stack regimen
Evidence
- Low
- Informal multi-peptide recovery stack with limited human evidence
Regulatory
- Not Fda Approved
Research
Mechanisms
None Listed
Evidence notes
- Low
- Informal multi-peptide recovery stack with limited human evidence
Administration
Subcutaneous
Research links
- None listed
Contraindications
- None listed
Components
- Bpc-157
- Tb-500-thymosin-beta-4
- Ghk-cu
- Kpv-lys-pro-val
Regulatory data
- Not Fda Approved
Aliases
- wolverine stack 4-compound
- wolverine stack extended
- wolverine blend
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations.